Copyright
©The Author(s) 2019.
World J Gastrointest Oncol. Apr 15, 2019; 11(4): 270-280
Published online Apr 15, 2019. doi: 10.4251/wjgo.v11.i4.270
Published online Apr 15, 2019. doi: 10.4251/wjgo.v11.i4.270
Figure 1 Association between mismatch repair deficiency/microsatellite instability and tumor immunity in gastrointestinal cancers.
A: Immune signatures are upregulated in the microsatellite instability-high (MSI-H) colon adenocarcinoma (COAD) vs the MSI low (MSI-L)/microsatellite stability (MSS) COAD (Mann-Whitney U test, P < 0.05); B: Immune signatures are upregulated in the MSI-H stomach adenocarcinoma (STAD) vs the MSI-L/MSS STAD. dMMR: Mismatch repair deficiency; MSI: Microsatellite instability; MSI-H: Microsatellite instability-high; MSI-L: Microsatellite instability-low; MSS: Microsatellite stability. aP < 0.05, bP < 0.01, cP < 0.001, MSI-H vs MSI-L/MSS. HLA: Human leukocyte antigen; IFN: Interferon; NK: Natural killer.
- Citation: He Y, Liu ZX, Jiang ZH, Wang XS. Identification of genomic features associated with immunotherapy response in gastrointestinal cancers. World J Gastrointest Oncol 2019; 11(4): 270-280
- URL: https://www.wjgnet.com/1948-5204/full/v11/i4/270.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v11.i4.270